Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Convertible Debt (2016 - 2017)

STRATA Skin Sciences (SSKN) has disclosed Convertible Debt for 4 consecutive years, with $13.4 million as the latest value for Q2 2017.

  • Quarterly Convertible Debt rose 23.67% to $13.4 million in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $13.4 million through Jun 2017, up 23.67% year-over-year, with the annual reading at $12.0 million for FY2016, N/A changed from the prior year.
  • Convertible Debt hit $13.4 million in Q2 2017 for STRATA Skin Sciences, up from $12.7 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $13.4 million in Q2 2017 to a low of $5.0 million in Q4 2014.
  • Historically, Convertible Debt has averaged $9.9 million across 4 years, with a median of $11.1 million in 2015.
  • Biggest five-year swings in Convertible Debt: skyrocketed 125.99% in 2015 and later grew 0.22% in 2016.
  • Year by year, Convertible Debt stood at $5.0 million in 2014, then soared by 127.41% to $11.4 million in 2015, then increased by 5.76% to $12.0 million in 2016, then grew by 11.29% to $13.4 million in 2017.
  • Business Quant data shows Convertible Debt for SSKN at $13.4 million in Q2 2017, $12.7 million in Q1 2017, and $12.0 million in Q4 2016.